You are here: Industry Insights > Business

News List

Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business prnasia
February 25, 2020
Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline health
Accor releases thought-leading white paper on the business of wellness and hospitality December 10, 2019
When stepping into a hotel these days, one cannot help but notice a growing wave of smoothie bowls, pilates poses.
Pii Appoints Business Executives contractpharma
July 03, 2019
Ideus, Grellner and McFarlane to head market engagement and business management activities.
Cambrex Makes Senior Appointments contractpharma
July 01, 2019
New roles to further support the company’s CDMO business.
PQE launches the new Digital Governance Business Line europeanpharmaceuticalreview
June 13, 2019
At PQE Group we foster innovation, efficiency and quality services for sustainable regulated compliance solutions.
Takeda to keep consumer business, looks outside Japan for selloffs instead fiercepharma
January 09, 2019
We just turned the page on 2018, with many Big Pharma companies having planned to exit the consumer health business, but Takeda doesn’t intend to join the party even though it’s in pressing need of money after a $58 billion acquisition.
Stada, eyeing OTC expansion, circles Bristol-Myers’ French Upsa business: report fiercepharma
October 11, 2018
Bristol-Myers Squibb could soon find a buyer for its French consumer health business amid continuous consolidation in the sector...
Allergan snaps up Bonti pharmatimes
September 18, 2018
Irish pharma Allergan is buying privately-held, clinical-stage US biotech Bonti for access to its novel, fast-acting neurotoxin programmes...
Shire to Break Up Business Into Two Companies biospace
January 10, 2018
Shire announced that it is splitting into two separate internal business units, Rare Disease Division and Neuroscience Division

Previous page 1 2 Next page